dalpiciclib
jiangsu hengrui pharmaceuticals
['bcsm', 'dawna-2', 'dalpiciclib', 'breast', 'rs onco']
#esmo22 news: the dawna-2 findings point to benefit of dalpiciclib plus aromatase inhibitor for first-line treatment of hr-positive advanced breast cancer in china #bcsm 
Medicine Matters #oncology publishes the latest news, commentary, research, and educational resources in a range of topics across oncology.